Enamine Ltd., a provider of drug discovery services empowered with the world’s largest collections of building blocks, fragments, and screening compounds, gave an update of its long-standing research collaboration with Endogena Therapeutics AG, a clinical-stage biotech company focused on the development of endogenous regenerative medicines.
Lytix Biopharma AS, a clinical stage immuno-oncology company, announces the election of a new Chairman of the Board at ‘s General Assembly.
Lytix Biopharma appoints new Chairman of the Board Read More »
Nona Biosciences announced it has entered into a collaboration agreement with Michael S. Diamond, MD, PhD, of Washington University in St. Louis to discover viral targets for which few or no human monoclonal antibodies currently exist, such as western equine encephalitis virus, rabies and severe fever with thrombocytopenia syndrome virus.
Nona Biosciences and Washington University Join Forces to Tackle Emerging RNA Viruses Read More »
ImmVira presented preclinical study results of CAR-T enabler oHSV product MVR-7011 through poster publication at the American Association for Cancer Research annual meeting.
Modalis Therapeutics Corporation announced that the abstract has been accepted for a presentation in the late-breaking session at the 26th Annual Meeting of The American Society of Gene & Cell Therapy, being held in Los Angeles CA on May 16-20, 2023.
Gamida Cell Ltd. announced the launch of a follow-on public offering of its ordinary shares and accompanying warrants to purchase its ordinary shares.
Gamida Cell Announces Launch of Public Offering of Securities – April 19, 2023 Read More »
Biophytis SA announced that it has received written notification from the Nasdaq Stock Market LLC dated April 14, 2022, indicating that Biophytis has regained compliance with he Nasdaq Global Select Market minimum bid price requirement.
Biophytis Regains Compliance with NASDAQ Minimum Bid Price Requirement Read More »
At the HIMSS conference in Chicago on Tuesday, pharmacists argued that state and federal regulators should allow them to do more to practice the full scope of their licenses.
Pharmacists stump for more active role in primary care Read More »
Shareholders are being asked to approve a proposal requiring the hospital operator to lay out its policies regarding emergency abortions, and to clarify its statement that it will follow “faith-based commitments.”
Tenet pressured to clarify emergency abortion policies Read More »
The final rule comes as a record 16.3 million Americans, spurred by COVID-19 incentives, signed up for ACA marketplace plans during the 2023 open enrollment period.
CMS walks back limits on non-standardized plan options, finalizes marketplace standards Read More »
